Ammonett Pharma
Midlothian, US · Delaware LLC
Founders & leadership
JB
John BrooksNamed on SEC filing
MO
Michael O. ThornerNamed on SEC filing
DJ
Daniel J. O'ConnellNamed on SEC filing
KP
Kevin P. TullyNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.4M disclosed across 1 round · 2018
▶$2.4MraisedAug 2018 · 7 investors · PharmaceuticalsRule 506(b)
▶$2.4MraisedAug 2018 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John BrooksDirector
- Michael O. ThornerExecutive Officer, Director
- Daniel J. O'ConnellDirector
- Kevin P. TullyExecutive Officer, Director
- Offering amount
- $2.4M
- Amount sold
- $2.4M
- First sale
- Jul 2018
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Ammonett Pharma raised?
- Ammonett Pharma has disclosed $2.4M raised across 1 round.
- Where is Ammonett Pharma headquartered?
- Ammonett Pharma is headquartered in Midlothian, US.